Loading clinical trials...
Loading clinical trials...
Protect the Head to Head: A Safety and Efficacy Assessment of the Emboliner Embolic Protection Device
Conditions
Interventions
Emboliner Embolic Protection
Sentinel Cerebral Protection
Locations
2
United States
NewYork-Presbyterian/Columbia University Medical Center
New York, New York, United States
Oklahoma Heart Institute
Tulsa, Oklahoma, United States
Start Date
May 4, 2023
Primary Completion Date
October 1, 2024
Completion Date
December 1, 2024
Last Updated
May 19, 2023
NCT06183944
NCT06189313
NCT05963698
NCT07015905
NCT03728166
NCT07102160
Lead Sponsor
Emboline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions